VALUE OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (R-METHUG-CSF) IN THE TREATMENT OF AGGRESSIVE NON-HODGKINS-LYMPHOMAS (NHL)WITH AN INTENSIVE WEEKLY CHEMOTHERAPY SCHEDULE - AN AUSTRIAN RANDOMIZED MULTICENTER TRIAL
Ma. Fridrik et al., VALUE OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (R-METHUG-CSF) IN THE TREATMENT OF AGGRESSIVE NON-HODGKINS-LYMPHOMAS (NHL)WITH AN INTENSIVE WEEKLY CHEMOTHERAPY SCHEDULE - AN AUSTRIAN RANDOMIZED MULTICENTER TRIAL, Blood, 84(10), 1994, pp. 10000023-10000023